SLC13A4 and cancer: A future study will be needed to determine whether the Nas2-dependent checkpoint can be properly activated in cancer cells, and how it might influence proteasome assembly and functions, since this Nas2-dependent checkpoint is needed to satisfy an increased demand for proteasome holoenzyme assembly (Fig. 5, C and D).